Citation: I. Talstad, WHAT IS WRONG WITH PROTHROMBIN TIME STANDARDIZATION BY INTERNATIONAL NORMALIZED RATIOS (INR), Thrombosis and haemostasis, 1997, pp. 790-791
Citation: I. Talstad, IMPROVED PROTHROMBIN TIME (PT) STANDARDIZATION BY CORRECTION OF THE PIVKA INHIBITOR, Thrombosis and haemostasis, 1997, pp. 2868-2868
Authors:
PILGER E
ERIKSSON H
GRUNGREIFF K
CARLSSON A
TALSTAD I
ANDERS O
SCHUCHARDT C
MUNCK D
LAFER M
Citation: E. Pilger et al., MULTICENTER STUDIES OF ULTRA-HIGH-DOSE, SHORT-DURATION STREPTOKINASE TREATMENT OF DEEP-VEIN THROMBOSIS, Current therapeutic research, 57(4), 1996, pp. 251-267
Authors:
HJORTH M
WESTIN J
DAHL IMS
GIMSING P
HIPPE E
HOLMBERG E
LAMVIK J
NIELSEN JL
LOFVENBERG E
PALVA IP
RODJER S
TALSTAD I
TURESSON I
WISLOFF F
ZADOR G
AMSLERNORDIN S
POLGARY M
ODEN A
WALLGREN A
WILHELMSEN L
HELLQVIST L
HASSELBLOM S
CARNESKOG J
LINDQVIST O
HOFFMAN P
OLSSON K
THOLEN A
STOLT CM
RINDNER A
SVENSSON R
VAART J
HANSEN S
ENGQVIST L
LANNEMYR O
NILSSON PG
LINNE I
LILJA G
TALLROTH G
HALLGREN J
ANDERSSON B
BILLSTROM R
PERSSON S
SAMUELSSON T
ODEBERG H
ADRIANSSON M
TOVE H
STOBEUS N
HABBERSTAD J
END T
DAHLEN M
ERIKSSON M
ANAGRIUS N
ARONSON D
NEZADAL L
ERIKSSON K
HEDENUS M
RYDE J
WESTIN L
ANDERSSON LO
BJURMAN A
FORSBERG K
FORS D
WIKSTROM S
THULE B
BOLSOY U
LENNERMO K
STRAND T
PALVA I
ALMQVIST A
ISOMAA B
OKSANEN K
EIKA C
LY B
BRANDT E
WEYDE K
FOSSUM C
LOVASEN K
SPARBY JA
JACOBSEN EM
RINDE M
NYHUS S
KAHRS J
STEEN T
GRAVDAHL H
BORGE L
GROTTUM KA
FLOTTEROD O
STROM BR
KNUTSEN H
DRIVENES A
PAULSEN J
RIIS S
HAUGE PW
NESTHUS I
COLL P
HOLE KH
SAETER T
SINDRE T
BERENTSEN S
NES H
VAGSTAD G
HEIKKELA R
SHAMMAS V
LODEMEL B
SKOGEN OR
SORUM Y
KVAMBE V
BULL O
JAEGER S
INGVALDSEN PG
PEDERSEN K
HANSEN LT
ONKIEHONG M
HAUGNES T
STEFANSEN D
GADEBERG O
ABILDGAARD N
JANS H
MOURITSANDERSEN T
NEUBAUER B
CLAUSEN NT
MAGNUSSON S
EYJOLFSSON G
BJORNSSON S
Citation: M. Hjorth et al., INTERFERON-ALPHA-2B ADDED TO MELPHALAN-PREDNISONE FOR INITIAL AND MAINTENANCE THERAPY IN MULTIPLE-MYELOMA - A RANDOMIZED, CONTROLLED TRIAL, Annals of internal medicine, 124(2), 1996, pp. 212
Citation: I. Talstad, PROPOSAL OF A SIMPLIFIED STANDARDIZATION METHOD OF THE ONE-STAGE PROTHROMBIN TIME (PT), Thrombosis and haemostasis, 73(6), 1995, pp. 1116-1116
Citation: I. Talstad, IS THE GOLDEN STANDARD OF ANTICOAGULATION (2-3 TIMES NORMAL CLOTTING TIME) STILL USEFUL, Thrombosis and haemostasis, 73(6), 1995, pp. 1240-1240
Citation: Cj. Bang et al., BLEEDING EFFECTS OF UNFRACTIONATED HEPARIN AND LOW-MOLECULAR-WEIGHT HEPARINS IN AN ANIMAL-MODEL, The European journal of surgery, 1994, pp. 23-29
Authors:
KELDSEN N
BJERRUM OW
DAHL IMS
DRIVSHOLM A
ELLEGAARD J
GADEBERG O
GIMSING P
GRONVOLD T
HANSEN MM
HIPPE E
LAMVIK J
LY B
SKARBOVIK A
TALSTAD I
THORLING K
WESENBERG K
WISLOFF F
Citation: N. Keldsen et al., MULTIPLE-MYELOMA TREATED WITH MITOXANTRONE IN COMBINATION WITH VINCRISTINE AND PREDNISOLONE (NOP REGIMEN) VERSUS MELPHALAN AND PREDNISOLONE- A PHASE-III STUDY, European journal of haematology, 51(2), 1993, pp. 80-85
Citation: I. Talstad et K. Korsbrekke, COMPARISON OF STANDARDIZATION METHODS OF THE ONE-STAGE PROTHROMBIN TIME (PT), Thrombosis and haemostasis, 69(6), 1993, pp. 662-662
Citation: I. Talstad et K. Korsbrekke, SIMPLIFIED STANDARDIZATION OF THE ONE-STAGE PROTHROMBIN TIME (PT), Thrombosis and haemostasis, 69(6), 1993, pp. 662-662